Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Evers, Georg, Beelen, Dietrich W., Braess, Jan, Sauerland, Cristina, Kolb, Hans-Jochem, Reichle, Albrecht, Holler, Ernst, Schwerdtfeger, Rainer, Arnold, Renate, Scheid, Christoph, Krug, Utz, Mueller-Tidow, Carsten, Schliemann, Christoph, Mikesch, Jan-Henrik, Lenz, Georg, Woermann, Bernhard J., Hiddemann, Wolfgang, Berdel, Wolfgang E. and Stelljes, Matthias (2018). Outcome of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Beyond First Complete Remission (CR1). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stelljes, Matthias, Krug, Utz, Beelen, Dietrich, Braess, Jan, Sauerland, Maria Cristina, Heinecke, Achim, Sauer, Tim, Tschanter, Petra, Thoennissen, Gabriela B., Kolb, Hans-Jochem, Reichle, Albrecht, Holler, Ernst, Schwerdtfeger, Rainer, Arnold, Renate, Scheid, Christof, Mueller-Tidow, Carsten, Woermann, Bernhard J., Hiddemann, Wolfgang, Berdel, Wolfgang E. and Buechner, Thomas (2012). Allogeneic Stem Cell Transplantation Versus Conventional Postremission Therapy for Acute Myeloid Leukemia in First Complete Remission: A Matched Pairs Analysis. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Stelljes, Matthias, Krug, Utz, Beelen, Dietrich W., Braess, Jan, Sauerland, Maria C., Heinecke, Achim, Ligges, Sandra, Sauer, Tim, Tschanter, Petra, Thoennissen, Gabriela B., Berning, Bjoerna, Kolb, Hans J., Reichle, Albrecht, Holler, Ernst, Schwerdtfeger, Rainer, Arnold, Renate, Scheid, Christoph, Mueller-Tidow, Carsten, Woermann, Bernhard J., Hiddemann, Wolfgang, Berdel, Wolfgang E. and Buechner, Thomas (2014). Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis. J. Clin. Oncol., 32 (4). S. 288 - 302. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Fri Mar 29 08:32:16 2024 CET.